The proposal aims to lower drug prices by forcing pharmaceutical companies to pay rebates to Medicare if they raise prices above the rate of inflation.
With one of the relatively newer but important anti-diabetic drugs, Vildagliptin manufactured by Novartis, losing patent protection in December, dozens of companies are readying plans to launch the generic version to get a slice of the action in the growing Rs 13,000-crore diabetes therapy. The cost of therapy is expected to reduce by over 50%.
Every year many parents get surprised with the birth of an affected child with genetic disorders. “Genetic disorders are passed on from generations to generations. It runs in the family genes. Genes are very powerful when it comes to the birth of a child” Says Dr. Rajni Khajuria, lab director at Igenomix.
In the 56th meeting of the DCC, it was proposed that Registered Medical Practitioners (RMP) shall supply ‘generic medicines’ only.
Stepping up efforts to curtail the ongoing diphtheria outbreak in Cox’s Bazar, WHO and UNICEF are working with Ministry of Health and Family Welfare to vaccinate over 350,000 children in the Rohingya camps and makeshift settlements with an additional dose of diphtheria vaccine.